aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2024. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
Realeve's core mission is to revolutionize headache treatment through advanced neurostimulation technology. The company focuses on developing miniaturized neurostimulation devices aimed at providing effective relief for severe headaches. Their innovative products target a niche market of patients seeking advanced medical solutions for chronic headache conditions.
Realeve has made significant strides in the medical device industry, setting new standards for headache treatment. Their cutting-edge technology has garnered attention for its potential to improve patient outcomes. The company's impactful work in neurostimulation highlights its commitment to advancing healthcare solutions.
Operating Status
Active
Ownership Type(s)
Venture Capital
Main Product(s)
Medical Devices
Technology
Neurostimulation
Tags
Healthtech
Model Types
Hardware
Revenue Type(s)
Recurring
Geographic Exposure
Americas
When was Realeve founded?
Realeve was founded in 2007.
Where is Realeve’s headquarters located?
Realeve’s headquarters is located in Mountain View, CA, US.
How many employees does Realeve have?
Realeve has 30 employees as of Feb 4, 2024.
How much has Realeve raised to-date?
As of July 05, 2023, Realeve has raised a total of $136.2M (USD) since Jan 1, 2016.
Add Comparison
Total Raised to Date
$136.2M
USD
Last Update Jan 1, 2016
Total Employees Over Time
30
As of Feb 2024
Realeve Address
355 Ravendale Dr
Mountain View,
California
94043
United States
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts